Rona Therapeutics is a pioneering nucleic acid therapeutics company to discover, develop and deliver transformative modular RNA medicines to treat patients globally. Rona Therapeutics is a global leader in nucleic acid innovative drug platform company, specializing in the treatment of metabolic diseases and neurological diseases. Rona Therapeutics is always committed to developing the best and first-in-class siRNA drugs with differentiation and innovation to address unmet needs and improve outcome in cardiovascular diseases, obesity, and MASH. In addition, Rona Therapeutics is unlocking potential of extra-hepatic delivery for neurological disorders and adipose/muscle delivery for various metabolic syndromes.
| Website | https://www.ronatherapeutics.com |
| Employees | 21 (12 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Nucleic Acid Therapeutics, Rna Therapeutics, Rna Modification, Rna Based Therapies, Rna Technology, Novel Therapeutics, Drug Delivery Systems, Targeted Therapies, Pharmaceutical Research, Biopharmaceutical, Precision Medicine |
| Competitors | Moderna Therapeutics, Gilead Sciences, Genentech, Regeneron, Amgen, Vertex Pharmaceuticals, The Janssen Pharmaceutical Companies of Johnson & Johnson, AstraZeneca, Novartis, Lilly India +43 more (view full list) |
Looking for a particular Rona Therapeutics employee's phone or email?
Stella Shi is the Founder, CEO of Rona Therapeutics.
12 people are employed at Rona Therapeutics.